Tamiflu Research a Mixed Report

One of my favorite literature researchers is Richard Bukata.
Here he talks about a marginal benefit for flu.
Tamiflu
http://www.epmonthly.com/www.epmonthly.com/features/current-features/tamiflu-know-the-research-before-you-prescribe/?utm_source=EPM+2014-1-23&utm_campaign=EPM+January+23+2014&utm_medium=email

3 thoughts on “Tamiflu Research a Mixed Report”

  1. Didn’t we have a national panic over lack of flu vaccine and Tamiflu shortages a few years ago? And the stuff has limited effectiveness.

  2. With Theraflu the illness at least feels shorter because you’re blissfully unconcious for most of it and at a fraction of the cost of Tamiflu.

  3. I think you’re being too kind by calling it a “mixed report”. Tamiflu™ simply has marginal, if even that, value.
    On the other hand, the similarly named Theraflu™, which is just a symptom reliever and makes no claims to actually “treat” the underlying viruses, does work. Well, at least for what it says, which id making you fell less horrible.

Leave a Reply

Your email address will not be published. Required fields are marked *

Discover more from JunkScience.com

Subscribe now to keep reading and get access to the full archive.

Continue reading